{"title":"SGLT2抑制剂治疗2型糖尿病:是时候了?","authors":"C. Davies","doi":"10.12968/pnur.2022.33.11.452","DOIUrl":null,"url":null,"abstract":"Sodium-glucose cotransporter-2 (SGLT2) inhibitors have a wide range of benefits in people with insufficiently controlled type 2 diabetes. Claire Davies provides an overview of these drugs to support safe use in primary care Sodium-glucose cotransporter-2 (SGLT2) inhibitors, sometimes also referred to as ‘gliflozins’ or ‘flozins’, are an established class of medications used for the treatment of insufficiently controlled type 2 diabetes. This article provides a summary of everything nursing staff in primary care need to know about the use of SGLT2 inhibitors for type 2 diabetes to support safe prescribing, monitoring and use.","PeriodicalId":79471,"journal":{"name":"Advanced practice nursing quarterly","volume":"112 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SGLT2 inhibitors in type 2 diabetes: time to flozinate?\",\"authors\":\"C. Davies\",\"doi\":\"10.12968/pnur.2022.33.11.452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sodium-glucose cotransporter-2 (SGLT2) inhibitors have a wide range of benefits in people with insufficiently controlled type 2 diabetes. Claire Davies provides an overview of these drugs to support safe use in primary care Sodium-glucose cotransporter-2 (SGLT2) inhibitors, sometimes also referred to as ‘gliflozins’ or ‘flozins’, are an established class of medications used for the treatment of insufficiently controlled type 2 diabetes. This article provides a summary of everything nursing staff in primary care need to know about the use of SGLT2 inhibitors for type 2 diabetes to support safe prescribing, monitoring and use.\",\"PeriodicalId\":79471,\"journal\":{\"name\":\"Advanced practice nursing quarterly\",\"volume\":\"112 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced practice nursing quarterly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12968/pnur.2022.33.11.452\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced practice nursing quarterly","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/pnur.2022.33.11.452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
SGLT2 inhibitors in type 2 diabetes: time to flozinate?
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have a wide range of benefits in people with insufficiently controlled type 2 diabetes. Claire Davies provides an overview of these drugs to support safe use in primary care Sodium-glucose cotransporter-2 (SGLT2) inhibitors, sometimes also referred to as ‘gliflozins’ or ‘flozins’, are an established class of medications used for the treatment of insufficiently controlled type 2 diabetes. This article provides a summary of everything nursing staff in primary care need to know about the use of SGLT2 inhibitors for type 2 diabetes to support safe prescribing, monitoring and use.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
